Accueil>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>β-Methylcrotonyl coenzyme A lithium

β-Methylcrotonyl coenzyme A lithium

Catalog No.GC66842

β-méthylcrotonyl coenzyme A lithium est un intermédiaire dans le métabolisme de la leucine et peut être utilisé comme substrat pour étudier la spécificité et la cinétique de β-méthylcrotonyl coenzyme A carboxylase (MCCase).

Products are for research use only. Not for human use. We do not sell to patients.

β-Methylcrotonyl coenzyme A lithium Chemical Structure

Cas No.: 108347-83-7

Taille Prix Stock Qté
10mg
2 332,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

β-Methylcrotonyl coenzyme A lithium is an intermediate in leucine metabolism and can be used as a substrate to study the specificity and kinetics of β-methylcrotonyl coenzyme A carboxylase (MCCase)[1].

β-Methylcrotonyl coenzyme A carboxylase, which is involved in amino acid metabolism, induces the activity of this enzyme in plant cells due to carbohydrate starvation and can be used as a new biochemical marker of the starvation-triggered autophagy process[1].

[1]. S Aubert, et al. Induction of beta-methylcrotonyl-coenzyme A carboxylase in higher plant cells during carbohydrate starvation: evidence for a role of MCCase in leucine catabolism. FEBS Lett. 1996 Apr 1;383(3):175-80.

Avis

Review for β-Methylcrotonyl coenzyme A lithium

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for β-Methylcrotonyl coenzyme A lithium

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.